News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement
|Articles|November 1, 2003

Pharmaceutical Executive

  • Pharmaceutical Executive-11-01-2003

Table of Contents

Table of Contents

Advertisement
External Link - article-75642.pdf

Articles in this issue

over 22 years ago

Article

The Ten Billion Dollar Molecule

over 22 years ago

Article

The Path to Smart R&D

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Advertisement

Related Content

Advertisement
Stock.adobe.com

The Ron Lanton Report: When Policy Becomes a Capital Event

ByRon Lanton,Nicholas Jacobus
March 20th 2026
Stock.adobe.com

Surfacing Themes at Access USA 2026

ByNicholas Jacobus,Ankit Jain
March 20th 2026

What Are the ‘Last Mile Issues’ Impacting Pharma?

ByMike Hollan,Nishith Rastogi
March 20th 2026
Pharmaceutical Executive Daily

Pharmaceutical Executive Daily: Analysis on TrumpRx List Pricing

ByNicholas Jacobus
March 19th 2026
Stock.adobe.com

TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report

ByNicholas Jacobus
March 19th 2026
Advertisement
Advertisement

Trending on PharmExec

1

What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them

2

TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report

3

What Governance Resets Should Pharma Companies Take in Response to AI?

4

Pharmaceutical Executive Daily: Analysis on TrumpRx List Pricing

5

FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us